Leica Biosystems to acquire Aperio
Leica Biosystems announced that an affiliate has entered into a definitive agreement to acquire Aperio, a provider of ePathology solutions.
Aperio will be integrated into Leica Biosystems, a provider of anatomical pathology solutions. Together, the two businesses will leverage each other's strengths to grow and expand digital pathology into the global life science and health care markets. The integrated business will provide solutions in each step of the anatomical pathology workflow, from sample preparation and staining, to imaging and reporting. The company will continue to offer both the Aperio and the existing Leica portfolio of Digital Pathology solutions, so that customers will enjoy more freedom to choose a solution that meets their individual needs.
Aperio's ePathology Solutions include whole slide scanners, a Network solution that enables remote, real-time viewing and easy distribution of images for peer review, collaboration, and consultation. Its Precision solution provides pathologists with easy-to-use quantitative image analysis to improve research and clinical productivity, reproducibility, and consistency. Customers include clinicians and researchers working in hospitals, reference laboratories, pharmaceuticals, and research institutions.Source: Leica Biosystems